Both the House and the Senate are considering legislation to support medical innovation. Reforms to the National Institutes of Health (NIH) and changes to the drug, biologic and device approval pathways at the Food and Drug Administration (FDA) The Senate's medical innovation package is that chamber's companion effort to the House's 21 st Century Cures initiative, which culminated in the House passage of H.R. 6 on July 10, 2015, on a vote of 344 to 77. This report provides for each of each of the 18 bills in the Senate and House medical innovation packages.